AZN — AstraZeneca Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for AstraZeneca, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,398	6,405	5,962	5,654	5,741
Net Total Accounts Receivable
Net Total Receivables	8,795	9,923	11,935	13,094	16,335
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26,244	22,593	25,054	25,827	28,723
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,171	9,449	10,502	11,647	14,703
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	105,363	96,483	101,119	104,035	114,074
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22,594	26,293	30,542	27,866	30,617
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	66,095	59,446	61,976	63,249	65,407
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	39,268	37,037	39,143	40,786	48,667
Total Liabilities & Shareholders' Equity	105,363	96,483	101,119	104,035	114,074
Total Common Shares Outstanding